149 related articles for article (PubMed ID: 3118788)
1. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
Neely AN; Holder IA
Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
[No Abstract] [Full Text] [Related]
2. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
[No Abstract] [Full Text] [Related]
3. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
Pennington JE; Pier GB; Sadoff JC; Small GJ
Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies for Pseudomonas aeruginosa pneumonia in the myelosuppressed host.
Pennington JE
Antibiot Chemother (1971); 1987; 39():51-9. PubMed ID: 3118791
[No Abstract] [Full Text] [Related]
7. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa. Treatment with intravenous immune globulin.
Holder IA; Naglich JG
Am J Med; 1984 Mar; 76(3A):161-7. PubMed ID: 6424445
[TBL] [Abstract][Full Text] [Related]
8. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
Pollack M
J Infect Dis; 1983 Jun; 147(6):1090-8. PubMed ID: 6406615
[TBL] [Abstract][Full Text] [Related]
9. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
Collins MS; Roby RE
Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas immunoglobulin and vaccine in burn patients.
Bose B
Lancet; 1981 Feb; 1(8217):435. PubMed ID: 6110056
[No Abstract] [Full Text] [Related]
11. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
Meitert T; Meitert E; Szegli G; Peligrad I
Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
[No Abstract] [Full Text] [Related]
12. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
Minukhin VV; Tsyganenko AIa
Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
Lieberman MM
Antibiot Chemother (1971); 1989; 42():193-202. PubMed ID: 2512837
[No Abstract] [Full Text] [Related]
15. [Experiences with a Pseudomonas immunoglobulin in artificially respirated patients with Pseudomonas pneumonia at a surgical intensive care unit].
Böhm D
Infection; 1987; 15(1):73-5. PubMed ID: 3106232
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas hyperimmune globulin: antibiotic treatment of experimental Pseudomonas sepsis in burned mice.
Holder IA; Neely AN
Antibiot Chemother (1971); 1989; 42():109-23. PubMed ID: 2512833
[No Abstract] [Full Text] [Related]
17. [The protective activity of 2 normal immunoglobulin preparations for intravenous administration in experimental Pseudomonas aeruginosa infection].
Vasilev ChL; Veleva KV; Tekelieva RKh; Pencheva PI
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):54-6. PubMed ID: 1907793
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
[No Abstract] [Full Text] [Related]
19. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection.
Montie TC; Drake D; Sellin H; Slater O; Edmonds S
Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785
[No Abstract] [Full Text] [Related]
20. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
